29Jul 2023
New Hope For Insulin-Resistant Diabetics?

New Hope For Insulin-Resistant Diabetics?

The study revealed FGF1 utilizes a different pathway, PDE4, to control blood glucose, providing a parallel system for patients with insulin resistance. This finding opens doors for drug development and fundamental research in managing high blood sugar and insulin resistance. The researchers aim to explore ways to enhance PDE4 activity through FGF1 modifications for better diabetes management.

  • #endo-diabetology

Like

Save

Share